Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma

计划入组 60 人 · 首次发布于 2006 年 3 月 14 日

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

计划入组 112 人 · 首次发布于 2024 年 10 月 2 日

Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer

计划入组 7 人 · 首次发布于 2014 年 11 月 25 日

177Lu-DOTA;GD2-SADA

two-step radioimmunotherapy (Y-mAbs Therapeutics)

Antibody guided radioimmunotherapy(Sigma-Tau BV)

Terbium-161 Radioimmunotherapy Shows Superior Efficacy Against Lymphoma in Preclinical Studies

Y-mAbs Presents Preclinical Pharmacokinetics Data for CD38-SADA Pretargeted Radioimmunotherapy at AACR 2025

Terbium-161 Radioimmunotherapy Shows Superior Efficacy Against Ovarian Cancer Stem Cells in Preclinical Study